window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 16, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

mRNA vaccine

  • Clinical Trials,Infectious Diseases,Vaccines

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    February 27, 2026
  • Biotech,Clinical Development,Clinical Trials,Infectious Diseases,Vaccines

    NeoVac reports Phase 1 and Phase 2 data for NeomiVac mRNA LNP covid-19 vaccine

    NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

    February 6, 2026
  • Biotech,Drug Development,Global health,Partnerships & Funding,RNA Therapeutics

    Hongene Biotech receives Gates Foundation grant for patent-free mRNA cap analogs

    Hongene Biotech has received a grant from the Gates Foundation [...]

    January 22, 2026
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Movers & Shakers,Oncology,Precision medicine

    PhoreMost appoints Pfizer drug discovery veteran Dr Adam Gilbert to scientific advisory board

    Appointment strengthens expertise in targeted protein degradation as company advances [...]

    July 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top